bladder cancer

Sesen Bio reports data update from phase 3 trial for high-risk non-muscle invasive bladder cancer
Sesen Bio reports data update from phase 3 trial for high-risk non-muscle invasive bladder cancer
Pharmaceutical Business Review
Sesen Bio
clinical trials
Vicinium
bladder cancer
Flag link:
Roche says test showed Tecentriq helped vs bladder cancer
Roche says test showed Tecentriq helped vs bladder cancer
Reuters
Roche
Tecentriq
bladder cancer
Flag link:
Did cancer clinical trials stay on track at ASCO 2019?
Did cancer clinical trials stay on track at ASCO 2019?
Pharmaforum
ASCO
clinical trials
cancer
ASCO 2019
bladder cancer
breast cancer
prostate cancer
pancreatic cancer
Flag link:
Inovio axes staffers, cancer program to 'sharpen focus,' save cash
Inovio axes staffers, cancer program to 'sharpen focus,' save cash
Fierce Biotech
Inovio
layoffs
bladder cancer
diagnostics
Flag link:
Cold virus strain could be used as therapy for bladder cancer – study
Cold virus strain could be used as therapy for bladder cancer – study
Pharmaforum
bladder cancer
coxsackievirus virus
Flag link:
Roche throws in the towel on Tecentriq bladder, myeloma trials
Roche throws in the towel on Tecentriq bladder, myeloma trials
Fierce Pharma
Roche
Tecentriq
bladder cancer
Multiple Myeloma
clinical trials
Flag link:
Clovis down after discontinuing rucaparib bladder cancer trial
Clovis down after discontinuing rucaparib bladder cancer trial
BioCentury
Clovis Oncology
Rubraca
bladder cancer
Flag link:
J&J's Balversa gets accelerated approval for bladder cancer
J&J's Balversa gets accelerated approval for bladder cancer
BioCentury
JNJ
Janssen
Balversa
bladder cancer
FDA
Flag link:
NanOlogy enrolls first patient in phase 1/2 clinical trial of NanoDoce to treat bladder cancer
NanOlogy enrolls first patient in phase 1/2 clinical trial of NanoDoce to treat bladder cancer
Pharmaceutical Business Review
NanOlogy
bladder cancer
NanoDoce
clinical trials
Flag link:
Key bladder cancer data pave way for Seattle Genetics to submit marketing application for armed antibody
Key bladder cancer data pave way for Seattle Genetics to submit marketing application for armed antibody
Endpoints
Seattle Genetics
Astellas
enfortumab vedotin
bladder cancer
Flag link:
miR Scientific Presents Urine Based Test for Detecting Prostate and Bladder Cancer
miR Scientific Presents Urine Based Test for Detecting Prostate and Bladder Cancer
CP Wire
miR Scientific
prostate cancer
bladder cancer
Flag link:
miR Scientific Presents Urine Based Test for Detecting Prostate and Bladder Cancer
miR Scientific
prostate cancer
bladder cancer
Flag link:
Merck limits orders for bladder cancer drug as demand outstrips supply
Merck limits orders for bladder cancer drug as demand outstrips supply
Fierce Pharma
Merck
bladder cancer
TICE BCG
Sanofi
Flag link:
Nektar, Bristol combo drug shows signs of tumor reduction in bladder cancer patients
Nektar, Bristol combo drug shows signs of tumor reduction in bladder cancer patients
Yahoo/Reuters
Nektar
Bristol-Myers Squibb
bladder cancer
NKTR-214
Opdivo
Flag link:
Bladder cancer readout sees Nektar shares hit
Bladder cancer readout sees Nektar shares hit
Fierce Biotech
Nektar Therapeutics
bladder cancer
NKTR-214
Opdivo
Bristol-Myers Squibb
Flag link:
Theralase AnnouncesTwo Patients Free of Bladder Cancer After Single Treatment in Ph Ib Study
Theralase AnnouncesTwo Patients Free of Bladder Cancer After Single Treatment in Ph Ib Study
CP Wire
Theralase
bladder cancer
TLD-1433
Flag link:
Theralase AnnouncesTwo Patients Free of Bladder Cancer After Single Treatment in Ph Ib Study
Theralase
bladder cancer
TLD-1433
Flag link:
FDA limits first-line bladder cancer labels for Keytruda, Tecentriq
FDA limits first-line bladder cancer labels for Keytruda, Tecentriq
Biopharma Dive
FDA
Merck
Keytruda
Roche
Tecentriq
bladder cancer
Flag link:
FDA warns of decreased survival in 2 studies of Keytruda, Tecentriq
FDA warns of decreased survival in 2 studies of Keytruda, Tecentriq
Biopharma Dive
FDA
clinical trials
oncologists
bladder cancer
Merck
Keytruda
Roche
Tecentriq
Flag link:
Merck's Keytruda shows up its rivals with NICE backing in bladder cancer
Merck's Keytruda shows up its rivals with NICE backing in bladder cancer
Fierce Pharma
Merck
Keytruda
NICE
bladder cancer
Flag link:

Pages